Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder [NA]
A completed clinical trial evaluating isradipine for cognitive enhancement in schizophrenia and schizoaffective disorder; results posted in …
-
FDA approval · 2018-11-30FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. The approval involves modifications…
-
FDA approval · 2018-11-28FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VRYALR (cariprazine) by Allergan, Inc., granting changes to the drug’s labeling.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone [Phase 3]
Phase 3 clinical trial comparing blonanserin to risperidone in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Staccato Loxapine Single Dose PK [Phase 1]
Phase 1 PK update for single-dose Staccato Loxapine in schizophrenia; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-11-19FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
The FDA approved the original ANDA application for olanzapine, granting generic status to HEC Pharm USA Inc. for this antipsychotic drug.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia [Phase 4]
Phase 4 clinical trial investigating pramlintide for weight reduction in schizophrenia-related weight gain; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: DECIFER: Depression and Citalopram In First Episode Recovery [Phase 4]
Phase 4 trial update for DECIFER evaluating depression and citalopram in first-episode recovery; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Safety and Efficacy of Cariprazine in Schizophrenia [Phase 3]
Phase 3 trial update assessing safety and efficacy of cariprazine in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia [Phase 4]
Phase 4 clinical trial update for aripiprazole lauroxil (ARISTADA) in schizophrenia with results posted.
-
FDA approval · 2018-11-05FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for GEODON (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2018-11-05FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Get Moving and Get Well - Pilot Study [NA]
Pilot clinical trial update for a movement and wellness program in psychiatric conditions; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Safety and Efficacy of Cariprazine in Patients With Schizophrenia [Phase 3]
Phase 3 trial update on safety and efficacy of cariprazine in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in Schizophrenia [NA]
Completed clinical trial evaluating repetitive transcranial magnetic stimulation for cognitive impairment in schizophrenia; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients [Phase 3]
Phase 3 randomized, double-blind trial evaluating tolerability of RBP-7000 in patients with schizophrenia; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy [Phase 2]
Phase 2 multiple ascending dose study in schizophrenia completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-22Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, and pharmacokinetics of OMS643762 in psychiatrically stable schizophrenia subjects ha…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia [Phase 3]
Long-term extension of lurasidone HCl (SM-13496) in schizophrenia completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia [Phase 3]
Phase III trial of SM-13496 (lurasidone HCl) in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia [Phase 3]
Phase 3 trial of SM-13496 (lurasidone HCl) in schizophrenia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Randomized Controlled Trial (RCT) of a Motivational Decision Support System [NA]
Randomized controlled trial of a motivational decision support system in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients [Phase 4]
Phase 4 trial evaluating whether long-term pharmacological antipsychotic treatment is necessary in schizophrenia and related psychotic disor…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia [Phase 2]
A Phase 2 proof-of-concept study evaluating intravenous sodium nitroprusside in adults with schizophrenia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia [Phase 3]
Phase 3 long-term study of RBP 7000 in schizophrenia has completed with results posted in 2018.